VEGFR-2 is downregulated in sestamibi-negative parathyroid adenomas.
Boban M ErovicDavid P GoldsteinSylvia L AsaStefan J JanikOzgur MeteJonathan C IrishPublished in: Head & neck (2019)
It is hypothesized that VEGFR-2 overexpression in parathyroid adenomas increases vascular permeability resulting in a higher uptake of sestamibi.